Table 3.
Bleeding rates and risk after colonic endoscopic mucosal resection according to antithrombotic agents
| None | Antiplatelets | Anticoagulants | Antiplatelets and anticoagulants | HBTa | |
|---|---|---|---|---|---|
| Polyp, n | 1304 | 297 | 74 | 28 | 31 |
| Size, mean ± SD, mm | 9.5 ± 5.9 | 8.6 ± 4.9b | 8.8 ± 6.0 | 8.8 ± 4.2 | 9.2 ± 5.1 |
| Morphology | 187 | 33 | 7 | 1 | 3 |
| pedunculated, n (%) | (14.3) | (11.1) | (9.5) | (3.6) | (9.7) |
| Bleeding, n (%) | 20 (1.53) | 4 (1.35) | 4 (5.48) | 2 (7.14) | 3 (9.68) |
| Odds | 1 | 0.88 | 3.67 | 4.95 | 6.88 |
| (95%CI) | (0.30–2.58) | (1.22–11.0) | (1.10–22.2) | (1.93–24.5) | |
| p | – | 0.81 | 0.021 | 0.038 | 0.020 |
aHeparin bridging therapy, bNone: Antiplatelets, p < 0.05